Matthew Maddocks1, Simon Mockett, Andrew Wilcock. 1. Hayward House Macmillan Specialist Palliative Care Cancer Unit, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, United Kingdom. matthew.maddocks@nottingham.ac.uk
Abstract
INTRODUCTION: Therapeutic exercise, although potentially beneficial, does not appear acceptable to many cancer patients. A greater understanding of the reasons for this is required. We have systematically reviewed the use of exercise in this group, identifying rates of uptake, adherence and completion along with factors influencing acceptability. METHODS: Searches were completed using relevant key words. Data on study design, patient group, exercise intervention, patient flow data and reasons for declining or withdrawing from a programme were independently extracted by two researchers. Rates of study uptake, completion and adherence were compared according to dichotomised patient or programme characteristics using Mann Whitney U test (p=0.05). Reasons provided when declining or withdrawing from a study were categorised. RESULTS: Sixty five studies were included. The majority contained groups made up entirely or predominantly of patients with breast cancer offered an aerobic or resistance exercise programme. The median [IQR] rates of uptake, adherence and completion were 63 [33-80]%, 84 [72-93]% and 87 [80-96]%, respectively. No characteristic influenced the proportion of patients taking up or completing a programme. The main reasons for refusal were disinterest or the impracticality of undertaking the programme and for withdrawal, medical complication or deterioration. CONCLUSIONS: The invitation to undertake a programme of therapeutic exercise is accepted by about two-thirds of patients. Rates of adherence and completion are relatively high, but overall, only about half of patients offered a programme complete one. There is a need to modify exercise programmes if they are to be acceptable for the majority of patients.
INTRODUCTION: Therapeutic exercise, although potentially beneficial, does not appear acceptable to many cancerpatients. A greater understanding of the reasons for this is required. We have systematically reviewed the use of exercise in this group, identifying rates of uptake, adherence and completion along with factors influencing acceptability. METHODS: Searches were completed using relevant key words. Data on study design, patient group, exercise intervention, patient flow data and reasons for declining or withdrawing from a programme were independently extracted by two researchers. Rates of study uptake, completion and adherence were compared according to dichotomised patient or programme characteristics using Mann Whitney U test (p=0.05). Reasons provided when declining or withdrawing from a study were categorised. RESULTS: Sixty five studies were included. The majority contained groups made up entirely or predominantly of patients with breast cancer offered an aerobic or resistance exercise programme. The median [IQR] rates of uptake, adherence and completion were 63 [33-80]%, 84 [72-93]% and 87 [80-96]%, respectively. No characteristic influenced the proportion of patients taking up or completing a programme. The main reasons for refusal were disinterest or the impracticality of undertaking the programme and for withdrawal, medical complication or deterioration. CONCLUSIONS: The invitation to undertake a programme of therapeutic exercise is accepted by about two-thirds of patients. Rates of adherence and completion are relatively high, but overall, only about half of patients offered a programme complete one. There is a need to modify exercise programmes if they are to be acceptable for the majority of patients.
Authors: Pantea Amin Javaheri; Cheryl Nekolaichuk; Robert Haennel; Matthew B Parliament; Margaret L McNeely Journal: Physiother Can Date: 2015 Impact factor: 1.037
Authors: Vanessa J Thomas; Catherine Seet-Lee; Michael Marthick; Birinder S Cheema; Michael Boyer; Kate M Edwards Journal: Support Care Cancer Date: 2019-05-21 Impact factor: 3.603
Authors: Wiebke Jensen; Freerk T Baumann; Alexander Stein; Wilhelm Bloch; Carsten Bokemeyer; Maike de Wit; Karin Oechsle Journal: Support Care Cancer Date: 2014-02-15 Impact factor: 3.603
Authors: Lara Groeneveldt; Gill Mein; Rachel Garrod; Andrew P Jewell; Ken Van Someren; Richard Stephens; Shirley P D'Sa; Kwee L Yong Journal: BMC Cancer Date: 2013-01-24 Impact factor: 4.430